Global Next Generation Cancer Diagnostic Devices Sales Market Report 2021

1 Next Generation Cancer Diagnostic Devices Market Overview

• 1.1 Next Generation Cancer Diagnostic Devices Product Scope
• 1.2 Next Generation Cancer Diagnostic Devices Segment by Type
  • 1.2.1 Global Next Generation Cancer Diagnostic Devices Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Next Generation Sequencing
  • 1.2.3 qPCR & Multiplexing
  • 1.2.4 Lab-on- a- chip (LOAC)
  • 1.2.5 Protein Microarrays
  • 1.2.6 DNA Microarrays
  • 1.2.7 Reverse Transcriptase-PCR (RT-PCR)
• 1.3 Next Generation Cancer Diagnostic Devices Segment by Application
  • 1.3.1 Global Next Generation Cancer Diagnostic Devices Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Biomarker Development
  • 1.3.3 CTC Analysis
  • 1.3.4 Proteomic Analysis
  • 1.3.5 Epigenetic Analysis
  • 1.3.6 Genetic Analysis
• 1.4 Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Next Generation Cancer Diagnostic Devices Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Next Generation Cancer Diagnostic Devices Price Trends (2016-2027)

2 Next Generation Cancer Diagnostic Devices Estimates and Forecasts by Region

• 2.1 Global Next Generation Cancer Diagnostic Devices Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Next Generation Cancer Diagnostic Devices Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2016-2021)
• 2.3 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Next Generation Cancer Diagnostic Devices Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
  • 2.4.2 Europe Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
  • 2.4.3 China Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
  • 2.4.4 Japan Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)
  • 2.4.6 India Next Generation Cancer Diagnostic Devices Estimates and Projections (2016-2027)

3 Global Next Generation Cancer Diagnostic Devices Competition Landscape by Players

• 3.1 Global Top Next Generation Cancer Diagnostic Devices Players by Sales (2016-2021)
• 3.2 Global Top Next Generation Cancer Diagnostic Devices Players by Revenue (2016-2021)
• 3.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2020)
• 3.4 Global Next Generation Cancer Diagnostic Devices Average Price by Company (2016-2021)
• 3.5 Manufacturers Next Generation Cancer Diagnostic Devices Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Next Generation Cancer Diagnostic Devices Market Size by Type

• 4.1 Global Next Generation Cancer Diagnostic Devices Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2016-2021)
• 4.2 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Type (2022-2027)

5 Global Next Generation Cancer Diagnostic Devices Market Size by Application

• 5.1 Global Next Generation Cancer Diagnostic Devices Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Next Generation Cancer Diagnostic Devices Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Next Generation Cancer Diagnostic Devices Price by Application (2016-2021)
• 5.2 Global Next Generation Cancer Diagnostic Devices Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Next Generation Cancer Diagnostic Devices Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Next Generation Cancer Diagnostic Devices Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Next Generation Cancer Diagnostic Devices Price Forecast by Application (2022-2027)

6 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures

• 6.1 North America Next Generation Cancer Diagnostic Devices Sales by Company
  • 6.1.1 North America Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
  • 6.1.2 North America Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
• 6.2 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
  • 6.2.1 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
• 6.3 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
  • 6.3.1 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2022-2027)

7 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures

• 7.1 Europe Next Generation Cancer Diagnostic Devices Sales by Company
  • 7.1.1 Europe Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
  • 7.1.2 Europe Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
• 7.2 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
  • 7.2.1 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
• 7.3 Europe Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
  • 7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)

8 China Next Generation Cancer Diagnostic Devices Market Facts & Figures

• 8.1 China Next Generation Cancer Diagnostic Devices Sales by Company
  • 8.1.1 China Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
  • 8.1.2 China Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
• 8.2 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
  • 8.2.1 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
• 8.3 China Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
  • 8.3.1 China 166 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 166 Sales Breakdown by Application (2022-2027)

9 Japan Next Generation Cancer Diagnostic Devices Market Facts & Figures

• 9.1 Japan Next Generation Cancer Diagnostic Devices Sales by Company
  • 9.1.1 Japan Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
  • 9.1.2 Japan Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
• 9.2 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
  • 9.2.1 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
• 9.3 Japan Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Next Generation Cancer Diagnostic Devices Market Facts & Figures

• 10.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Company
  • 10.1.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
• 10.2 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
  • 10.2.1 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Next Generation Cancer Diagnostic Devices Market Facts & Figures

• 11.1 India Next Generation Cancer Diagnostic Devices Sales by Company
  • 11.1.1 India Next Generation Cancer Diagnostic Devices Sales by Company (2016-2021)
  • 11.1.2 India Next Generation Cancer Diagnostic Devices Revenue by Company (2016-2021)
• 11.2 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Type
  • 11.2.1 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Type (2022-2027)
• 11.3 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Application
  • 11.3.1 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Next Generation Cancer Diagnostic Devices Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Next Generation Cancer Diagnostic Devices Business

• 12.1 Roche Holding Ltd.（Switzerland)
  • 12.1.1 Roche Holding Ltd.（Switzerland) Corporation Information
  • 12.1.2 Roche Holding Ltd.（Switzerland) Business Overview
  • 12.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.1.5 Roche Holding Ltd.（Switzerland) Recent Development
• 12.2 Abbott Laboratories(US)
  • 12.2.1 Abbott Laboratories(US) Corporation Information
  • 12.2.2 Abbott Laboratories(US) Business Overview
  • 12.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.2.5 Abbott Laboratories(US) Recent Development
• 12.3 Siemens Healthcare(Germany)
  • 12.3.1 Siemens Healthcare(Germany) Corporation Information
  • 12.3.2 Siemens Healthcare(Germany) Business Overview
  • 12.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.3.5 Siemens Healthcare(Germany) Recent Development
• 12.4 Agilent Technologies Inc(Germany)
  • 12.4.1 Agilent Technologies Inc(Germany) Corporation Information
  • 12.4.2 Agilent Technologies Inc(Germany) Business Overview
  • 12.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.4.5 Agilent Technologies Inc(Germany) Recent Development
• 12.5 Illumina Inc.(US)
  • 12.5.1 Illumina Inc.(US) Corporation Information
  • 12.5.2 Illumina Inc.(US) Business Overview
  • 12.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.5.5 Illumina Inc.(US) Recent Development
• 12.6 Becton Dickinson and Co.(US)
  • 12.6.1 Becton Dickinson and Co.(US) Corporation Information
  • 12.6.2 Becton Dickinson and Co.(US) Business Overview
  • 12.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.6.5 Becton Dickinson and Co.(US) Recent Development
• 12.7 QIAGEN N.V.(Germany)
  • 12.7.1 QIAGEN N.V.(Germany) Corporation Information
  • 12.7.2 QIAGEN N.V.(Germany) Business Overview
  • 12.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.7.5 QIAGEN N.V.(Germany) Recent Development
• 12.8 Affymetrix Inc.(US)
  • 12.8.1 Affymetrix Inc.(US) Corporation Information
  • 12.8.2 Affymetrix Inc.(US) Business Overview
  • 12.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.8.5 Affymetrix Inc.(US) Recent Development
• 12.9 Johnson & Johnson(US)
  • 12.9.1 Johnson & Johnson(US) Corporation Information
  • 12.9.2 Johnson & Johnson(US) Business Overview
  • 12.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.9.5 Johnson & Johnson(US) Recent Development
• 12.10 Thermo Fisher Scientific Inc.(US)
  • 12.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
  • 12.10.2 Thermo Fisher Scientific Inc.(US) Business Overview
  • 12.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
• 12.11 GE Healthcare(England)
  • 12.11.1 GE Healthcare(England) Corporation Information
  • 12.11.2 GE Healthcare(England) Business Overview
  • 12.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.11.5 GE Healthcare(England) Recent Development
• 12.12 Life Technologies Corp.(US)
  • 12.12.1 Life Technologies Corp.(US) Corporation Information
  • 12.12.2 Life Technologies Corp.(US) Business Overview
  • 12.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.12.5 Life Technologies Corp.(US) Recent Development
• 12.13 Luminex Corp.(US)
  • 12.13.1 Luminex Corp.(US) Corporation Information
  • 12.13.2 Luminex Corp.(US) Business Overview
  • 12.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.13.5 Luminex Corp.(US) Recent Development
• 12.14 Cepheid Inc.(US)
  • 12.14.1 Cepheid Inc.(US) Corporation Information
  • 12.14.2 Cepheid Inc.(US) Business Overview
  • 12.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.14.5 Cepheid Inc.(US) Recent Development
• 12.15 Allegro Diagnostics Corp.(Brazil)
  • 12.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
  • 12.15.2 Allegro Diagnostics Corp.(Brazil) Business Overview
  • 12.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Products Offered
  • 12.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development

13 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis

• 13.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices
• 13.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Next Generation Cancer Diagnostic Devices Distributors List
• 14.3 Next Generation Cancer Diagnostic Devices Customers

15 Market Dynamics

• 15.1 Next Generation Cancer Diagnostic Devices Market Trends
• 15.2 Next Generation Cancer Diagnostic Devices Drivers
• 15.3 Next Generation Cancer Diagnostic Devices Market Challenges
• 15.4 Next Generation Cancer Diagnostic Devices Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List